American National Bank & Trust’s GSK GSK Stock Holding History

American National Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29	Closed	-$1.42K	–	653
2025 Q4	$1.42K	Buy	+29	New	+$1.35K	﹤0.01%	649
2025 Q3	–	Sell	-1,300	Closed	-$49.9K	–	661
2025 Q2	$49.9K	Buy	+1,300	New	+$49.7K	0.01%	380
2024 Q3	–	Sell	-410	Closed	-$15.8K	–	515
2024 Q2	$15.8K	Buy	410 +193	+89%	+$8.12K	﹤0.01%	427
2024 Q1	$9.3K	Hold	217	–	–	﹤0.01%	421
2023 Q4	$8.04K	Sell	217 -2,188	-91%	-$78.5K	﹤0.01%	417
2023 Q3	$87.2K	Sell	2,405 -122	-5%	-$4.33K	0.01%	231
2023 Q2	$90.1K	Buy	2,527 +2,320	+1,121%	+$83.2K	0.02%	225
2023 Q1	$7.37K	Sell	207 -7	-3%	-$245	﹤0.01%	421
2022 Q4	$8K	Buy	+214	New	+$7.13K	﹤0.01%	397
2022 Q3	–	Sell	-202	Closed	-$11K	–	606
2022 Q2	$11K	Buy	+202	New	+$11.2K	﹤0.01%	289
2016 Q2	–	Sell	-214	Closed	-$11K	–	252
2016 Q1	$11K	Hold	214	–	–	﹤0.01%	174
2015 Q4	$11K	Hold	214	–	–	﹤0.01%	188
2015 Q3	$10K	Buy	+214	New	+$11.1K	﹤0.01%	197

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

American National Bank & Trust's GSK Position: Q1 2026 in Review

American National Bank & Trust sold out of GSK (GSK) in Q1 2026, closing a stake of 29 shares — an estimated $1.42K sold.

American National Bank & Trust first reported a position in GSK in Q3 2015 and held it in 13 quarters. The position peaked at $90.1K in Q2 2023. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

American National Bank & Trust reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
American National Bank & Trust sold 29 GSK shares in Q1 2026, an estimated $1.42K.
American National Bank & Trust first reported a position in GSK in Q3 2015 and held it in 13 quarters.
American National Bank & Trust's GSK position peaked at $90.1K in Q2 2023.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on American National Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.